Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CCR1 | P32246 | 3/20 | 0.48 |
| ▸ | CCR5 | P51681 | 3/20 | 0.48 |
| ▸ | CCR8 | P51685 | 3/20 | 0.48 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.41 |
| ▸ | SPR | P35270 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | METAP1 | P53582 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30362730 | 0.97 | KDM4E (0.46) | KDM4EALDH1A1SMN1; SMN2CCR1CCR5 | |
| SCHEMBL308538 | 0.86 | KDM4E (0.61) | KDM4EALDH1A1SMN1; SMN2CCR1CCR5 | |
| SCHEMBL12176177 | 0.86 | KDM4E (0.39) | KDM4EALDH1A1SMN1; SMN2CCR1CCR5 | |
| SCHEMBL12893405 | 0.86 | CCR1 (0.52) | KDM4EALDH1A1SMN1; SMN2CCR1CCR5 | |
| SCHEMBL29218030 | 0.83 | PTGS1 (0.41) | KDM4EALDH1A1SMN1; SMN2CCR1CCR5 | |
| SCHEMBL16210551 | 0.83 | MEN1 (0.47) | KDM4EALDH1A1SMN1; SMN2PTGS1PTGS2 | |
| SCHEMBL4803 | 0.81 | ASIC3 (0.59) | KDM4EALDH1A1SMN1; SMN2GRM5LMNA | |
| SCHEMBL5760081 | 0.81 | SMN1; SMN2 (0.44) | KDM4EALDH1A1SMN1; SMN2SPRPTGS1 | |
| SCHEMBL31645963 | 0.81 | ASIC3 (0.59) | KDM4EALDH1A1SMN1; SMN2GRM5LMNA | |
| SCHEMBL28660470 | 0.81 | RAD51 (0.37) | KDM4EALDH1A1SMN1; SMN2CCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079873-A | Dipyridyl iron complex, preparation method thereof and electrolyte | — | 2026-05-26 | — | — | CN | claimed |
| CN-116606318-B | Preparation method of phosphamide derivative | 安阳师范学院 | 2025-05-27 | — | — | CN | claimed |
| CN-120006346-A | Catalyst for electrochemical ammoxidation and preparation method thereof | 大连理工大学 | 2025-05-16 | — | — | CN | claimed |
| CN-119746830-A | Preparation method, adsorption and desorption method of lithium isotope adsorbent | 中国科学院青海盐湖研究所 | 2025-04-04 | — | — | CN | claimed |
| CN-118388551-A | Binuclear ruthenium complex and preparation method and application thereof | 中山大学 | 2024-07-26 | — | — | CN | claimed |
| CN-116870962-A | Multiphase nitrogen-containing ligand modified supported ruthenium catalyst and preparation and application thereof | 中国科学院兰州化学物理研究所 | 2023-10-13 | — | — | CN | claimed |
| CN-116606318-A | Preparation method of phosphamide derivative | 安阳师范学院 | 2023-08-18 | — | — | CN | claimed |
| US-20230167144-A1 | PREPARATION AND ITS APPLICATION OF A CYANIDE-BRIDGED METAL ORGANIC COMPOUND WITH INTRAMOLECULAR MAGNETIC TRANSFORMATION | Hubei Jingmen Industrial Technology Research Institute Co., Ltd. (CN) | 2023-06-01 | — | — | US | claimed |
| CN-115869923-A | Oxygen absorbing material, preparation method thereof and prepared adsorbing material capable of adsorbing oxygen and organic solvent simultaneously | 威格科技(苏州)股份有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-115819472-A | Polypyridine metal complex and preparation method thereof | 广州大学 | 2023-03-21 | — | — | CN | claimed |
| CN-114456294-A | Preparation method of organic porous material and application of organic porous material in preparation of ultra-high molecular weight polymer | 合肥工业大学 | 2022-05-10 | — | — | CN | claimed |
| CN-108358970-A | A kind of structure and preparation method of red emission ionic type iridium complex | 昆明贵金属研究所 | 2018-08-03 | — | — | CN | claimed |
| CN-105131043-A | Preparation and application of dipyridyl ruthenium dye with phenothiazine derivative as ligand | UNIV SICHUAN | 2015-12-09 | — | — | CN | claimed |
| US-12636366-B2 | Ruthenium (II) complexes and conjugates thereof for use as photosensitizer agent in photodynamic therapy | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE PARIS (FR) | 2026-05-26 | — | — | US | disclosed |
| CN-122079873-A | Dipyridyl iron complex, preparation method thereof and electrolyte | — | 2026-05-26 | — | — | CN | disclosed |
| WO-2026107178-A1 | GLOBAL AFFINITY PROFILING OF MOLECULAR INTERACTIONS USING COMPETITIVE ENRICHMENT | CORNELL UNIVERSITY (US) | 2026-05-21 | — | — | WO | disclosed |
| WO-1995029924-A1 | PHOSPHONATED POLYPYRIDYL COMPOUNDS AND THEIR COMPLEXES | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 1995-11-09 | — | — | WO | disclosed |
| EP-0360820-B1 | OLIGOBIPYRIDINE LIGANDS, PROCESS FOR OBTAINING THEM AND APPLICATION AS COMPLEXING AGENTS | CIS BIO INTERNATIONAL (FR) | 1992-08-19 | — | — | EP | disclosed |
| EP-0360820-A1 | OLIGOBIPYRIDINE LIGANDS, PROCESS FOR OBTAINING THEM AND APPLICATION AS COMPLEXING AGENTS. | ORIS SA (FR) | 1990-04-04 | — | — | EP | disclosed |
| WO-1988008419-A1 | OLIGOBIPYRIDINE LIGANDS, PROCESS FOR OBTAINING THEM AND APPLICATION AS COMPLEXING AGENTS | COMPAGNIE ORIS INDUSTRIE S.A. (FR) | 1988-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12636366-B2 | Ruthenium (II) complexes and conjugates thereof for use as photosensitizer agent in photodynamic therapy | FABP2, APC, TP53 | KDM4E 4759/4885ALDH1A1 2418/4885SMN1; SMN2 2206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.